- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Aerami Therapeutics Holdings Inc.
BioCentury | Feb 26, 2025
Management Tracks
Lindsay Androski named CEO of Arbutus
Plus: CMO Maria Koehler steps down at Repare, and updates from Isomab, Crescent, Ottimo and Senti Bio
BioCentury | Jun 1, 2023
Management Tracks
Alkermes picks Loew to lead oncology spinout
Plus: Two new SVPs at Dragonfly, and updates from Abilita, OcuTerra and PineTree
BioCentury | May 5, 2023
Management Tracks
Walensky resigning as CDC director
Plus: Riva to lead Transgene as CEO and updates from Aerami, Ginkgo and Tris
BioCentury | Dec 22, 2022
Management Tracks
Genentech bolsters marketing team
Plus: Greene becomes chief investment officer at Hevolution, and updates from Aerami and Curate
BioCentury | Jun 22, 2022
Management Tracks
Yerxa leaving Foundation Fighting Blindness to become Opus’ permanent CEO
Plus Biden to nominate Arati Prabhakar as director of OSTP, and updates from Oncorena, Panorama, Indivior, Prolacta and more
BioCentury | Jun 16, 2022
Management Tracks
Dealhoy becomes CBO at Deciphera
Plus new CSO at GlycoEra, and updates from Geron, Ysios, CBC and more
BioCentury | Aug 13, 2020
Emerging Company Profile
RA-incubated Aerovate to deploy $72.6M series A for inhaled imatinib for PAH
Powder aerosol formulations designed to avoid systemic effects that tripped up Novartis’ oral version
Items per page:
1 - 7 of 7